PolicyWatch

Aug
16
Shanghai Enhances Payment Mechanisms to Drive Pharma and Medical Innovation

Shanghai Enhances Payment Mechanisms to Drive Pharma and Medical Innovation

Shortly after the National Healthcare Security Administration (NHSA) introduced its more industry-friendly renewal rules for older NRDL-negotiated drugs, the Shanghai
6 min read
Aug
02
China Implements More Moderate and Predictable Price Reduction for Older NRDL-Negotiated Drugs

China Implements More Moderate and Predictable Price Reduction for Older NRDL-Negotiated Drugs

In late June, the National Healthcare Security Administration (NHSA) commenced the 2023 National Reimbursement Drug List (NRDL) Dynamic Update, aiming
4 min read